[Federal Register Volume 69, Number 79 (Friday, April 23, 2004)]
[Notices]
[Pages 22054-22055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-9237]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-36-04]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 498-1210. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503 or by fax 
to (202) 395-6974. Written comments should be received within 30 days 
of this notice.
    Proposed Project: Thyroid Disease in Persons Exposed to Radioactive 
Fallout from Atomic Weapons Testing at the Nevada Test Site: Phase III 
(OMB No. 0920-0504)--Extension--National Center for Environmental 
Health (NCEH), Centers for Disease Control and Prevention (CDC).
    In 1997, the National Cancer Institute (NCI) released a report 
entitled, ``Estimated Exposures and Thyroid Doses Received by the 
American People from I-131 in Fallout Following Nevada Nuclear Bomb 
Test.'' This report provided county-level estimates of the potential 
radiation doses to the thyroid gland of American citizens resulting 
from atmospheric nuclear weapons testing at the Nevada Test Site (NTS) 
in the 1950s and 1960s. The Institute of Medicine (IOM) conducted a 
formal peer review of the report at the request of the Department of 
Health and Human Services. In the review, IOM noted that the public 
might desire an assessment of the potential health impact of nuclear 
weapons testing on American populations. The IOM also suggested that 
further studies of the Utah residents who have participated in previous 
studies of radiation exposure and thyroid disease might provide this 
information.
    CDC, National Center for Environmental Health proposes to conduct a 
study of the relation between exposure to radioactive fallout from 
atomic weapons testing and the occurrence of thyroid disease on an 
extension of a cohort study previously conducted by the University of 
Utah, Salt Lake City, Utah. This study is designed as a follow-up to a 
retrospective cohort study begun in 1965. This is the third examination 
(hence Phase III) of a cohort of individuals comprised of persons who 
were children living in Washington County, Utah, and Lincoln County, 
Nevada, in 1965 (Phase I) and who were presumably exposed to fallout 
from above-ground nuclear weapons testing at the Nevada Test Site in 
the 1950s. The cohort also includes a control group comprised of 
persons who were children living in Graham County, Arizona, in 1966 and 
presumably unexposed to fallout.
    The study headquarters will be at the University of Utah in Salt 
Lake City, Utah. The field teams will spend the majority of their time 
in the urban areas nearest the original counties if the same pattern of 
migration holds same as that was found in Phase II. These urban areas 
include: St. George, Utah; the Wasatch Front in Utah; Las Vegas, 
Nevada; Phoenix/Tucson, Arizona; and Denver, Colorado. In addition, 
some time will be spent in California as a number of subjects were 
relocated there during the time of Phase II. The purpose of Phase III 
is three-fold. First, the participants in Phase II will be re-examined 
for occurrence of thyroid neoplasia and other diseases since 1986, and 
residents of the three counties who moved before they could be included 
in the original cohort will be located and examined. Second, disease 
incidence will be analyzed in addition to period prevalence as used in 
the Phase II analysis, and incidence analysis will allow for greater 
power to detect increased risk of disease in the exposed population 
through the use of person-time. Third, disease specific mortality rates 
for Washington County, Utah, and a control county, Cache County, Utah, 
will be compared to people who lived in these two counties during the 
time of above-ground testing. This comparison will determine if the 
risk of mortality in Washington County (the exposed group) is 
significantly greater than Cache County (the control group). CDC, NCEH 
is requesting a three-year clearance. The estimated annualized burden 
is 3,368 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
                           Respondents                              respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Telephone Location Script.......................................           1,200               1            5/60
Telephone Location Script (return letter).......................              67               1            5/60
Refusal Telephone Script........................................              50               1            5/60
Recruitment Next of Kin Telephone Script........................              75               1            5/60
Recruitment & Appointment Script................................             960               1            5/60
Broken Appointment Telephone Script.............................              40               1            5/60
Exposure Questionnaire..........................................             167               1           90/60

[[Page 22055]]

 
Questionnaire Preparation Booklet...............................             960               1           30/60
Group Member Information........................................             960               1            5/60
Consent Forms...................................................             960               1            5/60
Interview Booklet...............................................             167               1           30/60
Medical History Questionnaire (male)............................             520               1               2
Medical History Questionnaire (female)..........................             520               1               2
Medical Records Release Telephone Script........................              40               1            5/60
Thyroid Exam....................................................             520               1               1
Travel Form.....................................................              80               1           20/60
Residence History...............................................             167               1            5/60
Refusal Questionnaire...........................................               8               1            5/60
----------------------------------------------------------------------------------------------------------------


    Dated: April 16, 2004.
Bill J. Atkinson,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 04-9237 Filed 4-22-04; 8:45 am]
BILLING CODE 4163-18-P